Amneal gets key win in US district court before Federal Circuit hearing on Orange Book delisting order
MLex Summary: Teva Pharmaceuticals's efforts to import “active drug” limitations to the claims of five patents at the center of a contentious appeal to the US Court of Appeals for the...To view the full article, register now.
Already a subscriber? Click here to view full article